These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4479242)

  • 21. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total-body potassium in hypertension patients during prolonged diuretic therapy.
    Edmonds CJ; Jasani B
    Lancet; 1972 Jul; 2(7766):8-12. PubMed ID: 4113653
    [No Abstract]   [Full Text] [Related]  

  • 23. The physiology of loop diuretic action.
    Reeves WB; Molony DA
    Semin Nephrol; 1988 Sep; 8(3):225-33. PubMed ID: 3059427
    [No Abstract]   [Full Text] [Related]  

  • 24. Body potassium after short-term diuretic therapy with clopamide.
    Bauer FK
    J Clin Pharmacol J New Drugs; 1969; 9(1):16-23. PubMed ID: 5250308
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diuretics--loss of potassium--potassium deficiency and potassium substitution].
    Truniger B
    Schweiz Med Wochenschr; 1978 Jul; 108(27):1009-12. PubMed ID: 663594
    [No Abstract]   [Full Text] [Related]  

  • 26. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I; Yalcin S; Ozhan H
    Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Behavior of renin, aldosterone, electrolytes and extracellular spaces during combination diuretic therapy in hypertensive patients].
    Hilfenhaus M; Erbler HC; Mariss P; Liebau H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():299-302. PubMed ID: 611970
    [No Abstract]   [Full Text] [Related]  

  • 28. Loop diuretics: from the Na-K-2Cl transporter to clinical use.
    Shankar SS; Brater DC
    Am J Physiol Renal Physiol; 2003 Jan; 284(1):F11-21. PubMed ID: 12473535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diuretics].
    Schwartz J; Bloch R; Imbs JL; Spach MO
    Pathol Biol (Paris); 1986 Sep; 34(7):861-85. PubMed ID: 3537932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular pharmacology in diuretics].
    Iwao H
    Nihon Rinsho; 1992 Dec; 50(12):3004-9. PubMed ID: 1491451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of diuretics in the treatment of ascites in patients with cirrhosis].
    Bourgeois N; Devaere S; Adler M; Cremer M
    Acta Gastroenterol Belg; 1990; 53(2):256-60. PubMed ID: 2267905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extracellular potassium concentration and fasting blood sugar in diabetes mellitus].
    Schwarzbach W
    Med Klin; 1970 Jun; 65(24):1161-3. PubMed ID: 5517341
    [No Abstract]   [Full Text] [Related]  

  • 34. [Spironolactone, potassium chloride and hyperkalemia in patients with kidney failure].
    Elo H
    Duodecim; 1992; 108(19):1708-10. PubMed ID: 1366200
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination diuretic drug therapy.
    Reubi FC
    Cardiovasc Clin; 1971; 2(3):197-210. PubMed ID: 4950425
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diuretics for therapy of patients with hypertension].
    Morimoto S
    Nihon Rinsho; 1997 Aug; 55(8):2039-44. PubMed ID: 9284421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 38. [Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)].
    Esch I; Placheta P; Gaul G
    Wien Klin Wochenschr; 1976 Jun; 88(13):415-8. PubMed ID: 824860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducing hyperkalemia by converting enzyme inhibitors and heparin.
    Durand D; Ader JL; Rey JP; Tran-Van T; Lloveras JJ; Bernadet P; Suc JM
    Kidney Int Suppl; 1988 Sep; 25():S196-7. PubMed ID: 3184611
    [No Abstract]   [Full Text] [Related]  

  • 40. Spironolactone for all hypertensive patients?
    Rosendorff C
    J Hypertens; 2010 Jan; 28(1):13-4. PubMed ID: 20016304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.